Tulane Cancer Center Invited Speaker Series(Supported by the Louisiana Cancer Research Consortium) (Sponsored CME series) 2009 - 2010 TCC Seminar Series Schedule Time & Location:
Schedule for 2010 (For LCRC Speakers from 2006 to 2007, Click Here.) (For LCRC Speakers from 2008 to 2009, Click Here.) Statement of Need: The purpose of the Louisiana Cancer Research Consortium Grand Rounds is to provide a forum for the physicians in the Consortium in which they will be able to improve their personal competency in designing appropriate treatment protocols for patients presenting with various cancers; foster faculty communication , inter-professional teaming and professionalism; meet the quality improvement guidelines in cancer care; stay abreast of the latest research and developments in cancer. Target Audience:
Objectives: After participating in this CME Activity, the participant should be better able to:
Accreditation/Designation of Credit: Tulane University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. Tulane University Health Sciences Center designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Tulane University Health Sciences Center presents this activity for educational purposes only and does not endorse any product, content of presentation or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentation is provided solely by presenters who have been selected because of their recognized expertise. Facilitated by: The Tulane University Health Sciences Center - Center for Continuing Education Faculty Disclosure: It is the policy of Continuing Education at Tulane University Health Sciences Center to plan and implement all of its educational activities in accordance with the ACCME's Essential Areas and Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME's Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit TM is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity. Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental or investigational drugs or devices must also be made known to the audience. |
2010 |
Location |
Speaker |
Title |
|
Feb 25 |
Tulane |
Ramesh Shivdasani, MD, PhD |
"Molecular Control of Cell Differentiation in Normal and Malignant Gastrointestinal Epithelium" | |
|
|
|||
Mar 25 |
Tulane |
Francesco DeMayo, PhD |
Molecular Regulators of Uterine and Pulmonary Epithelial Transformation: Investigations Using Mouse Models |
|
Apr 8 |
Tulane |
Myles Brown, MD Professor of Medicine Department of Medical Oncology |
Epigenomics and Cistromics of Hormone Dependent Cancers | |
|
|
|||
Apr 29 |
Tulane |
Joyce Slingerland, MD, PhD, FRCP |
||
|
|
|||
May 13 |
Tulane |
Rakesh Kumar, PhD Professor and Chairman George Washington University Dept of Biochemistry and Molecular Biology |
||
|
|
|||
June 10 |
Tulane |
Jose R. Conejo-Garcia, MD, PhD |
||
June 24 |
Tulane |
Richard Shen, PhD Vice President |
||
July 8 |
Tulane |
Geoff Rosenfeld, M.D. Investigator |
||
July 22 |
Tulane |
Dales Hedges, PhD Assistant Professor of Human Genetics |
||
|
|
|||
Aug 12 |
Tulane |
Bharat Aggarwal, PhD Department of Experimental Therapeutics University of Texas MD Anderson Cancer Center |
||
|
|
|||
Sept 9 |
Tulane |
Dean Tang, MD, Ph.D Associate Professor Science Park -Research Division M.D. Anderson Cancer Center |
||
|
|
|||
Sept 23 |
Tulane |
Tim H. M. Huang, PhD |
||
Sept 30 |
Tulane |
Eric Snapp, PhD |
||
|
|
|||
Oct 14 |
Tulane |
Sara Sukamar, PhD Professor of Oncology and Pathology John Hopkins University School of Medicine McKusick-Nathans Institute of |
||
|
|
|
||
For more information, please contact:
Kasi Guillot
Phone: 504-988-3068
email: kguillo@tulane.edu
Academic Coordinator for the Tulane Cancer Center Invited Speaker Series:
Matthew E. Burow, PhD
email: mburow@tulane.edu
|
||||||||||||




